tm logo
VIVA-PROE
REGISTERED

on 05 Feb 2024

Last Applicant/ Owned by

SIEMENS HEALTHCARE DIAGNOSTICS INC.

511 Benedict Ave.Tarrytown NY 10591

US

Serial Number

2136809 filed on 30th Jun 2021

Registration Number

TMA1220439 registered on 05th Feb 2024

Registration expiry Date

30th Jun 2031

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

VIVA-PROE

Trademark usage description

clinical laboratory analyzers, namely, blood and biological sample chemistry analyzers and parts thereof for measuring, testing and analyzing blood, b Read More

Classification Information


Class [009]
Clinical laboratory analyzers, namely, blood and biological sample chemistry analyzers and parts thereof for measuring, testing and analyzing blood, bodily fluids and other liquid samples in the field of drug-of-abuse testing, diagnostic therapeutic drug monitoring, therapeutic drug testing, blood serum toxicology testing, analyte detecting, and specimen validity testing; computer software for use in medical diagnosis and testing, namely drug-of-abuse testing, diagnostic therapeutic drug monitoring, therapeutic drug testing, blood serum toxicology testing, analyte detecting, and specimen validity testing


Classification kind code

11

Mark Details


Serial Number

2136809

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 12th Jan 2023
Agent Changed
Submitted for opposition 22
on 04th Jan 2023
Search Recorded
Submitted for opposition 20
on 04th Jan 2023
Examiner's First Report
Submitted for opposition 223
on 04th Jan 2023
Total Provisional Refusal
Submitted for opposition 256
on 01st Aug 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 30th Sep 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 29th Sep 2021
Formalized
Submitted for opposition 1
on 29th Sep 2021
Created
Submitted for opposition 228
on 30th Jun 2021
International Registration
Submitted for opposition 30
on 30th Jun 2021
Filed